Stacey Ehrenberg Buchner, MD
Assistant Professor, Obstetrics and Gynecology, CWRU School of Medicine
High Risk Obstetrics, Diabetes in Pregnancy, Maternal Fetal Medicine, Prenatal Diagnosis, Ultrasound
Education & Training
2000, University of Michigan
Medical / Professional School(s):
2006, University of Toledo College of Medicine
2010, Obstetrics and Gynecology - UH Case Medical Center
2013, Maternal and Fetal Medicine - University of Michigan Medical Center/University of Michigan Health System
Surveillance of fetal lung lesions using the congenital pulmonary airway malformation volume ratio: natural history and outcomes.
Macardle CA, Ehrenberg-Buchner S, Smith EA, Dillman JR, Mychaliska GB, Treadwell MC, Kunisaki SM
Vanishing fetal lung malformations: Prenatal sonographic characteristics and postnatal outcomes.
Kunisaki SM, Ehrenberg-Buchner S, Dillman JR, Smith EA, Mychaliska GB, Treadwell MC
Fetal lung lesions: can we start to breathe easier?
Ehrenberg-Buchner S, Stapf AM, Berman DR, Drongowski RA, Mychaliska GB, Treadwell MC, Kunisaki SM
Ectopic pregnancy: role of laparoscopic treatment.
Ehrenberg-Buchner S, Sandadi S, Moawad NS, Pinkerton JS, Hurd WW
Patient Satisfaction Reviews
About Our Survey
At University Hospitals, we believe in providing patients with all the information they need to make educated decisions about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians. We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for every individual who sees a UH doctor.
There are no comments for this practitioner.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Stacey Ehrenberg Buchner, MD did not disclose any Outside Relationships with Industry.